Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim versus filgrastim after high-dose chemotherapy with autologous PBSC
2006-001409-27Phase 2Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in hematopoietic malignancies and Nonhematologic neoplasms comparing Pegfilgrastim with Filgrastim (2 arms). Primary endpoint: Non-inferiority of pegfilgrastim versus filgrastim. Started Oct 2006; status: completed.
02
Drugs
pegfilgrastimfilgrastim
03
Conditions
hematopoietic malignanciesNonhematologic neoplasms
Beyond the preview
Go deeper on 2006-001409-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001409-27.